Lachlan Brown
When I first picked up a book on Buddhism in a Melbourne library as a teenager, I had no idea that one of the world’s most prestigious universities was quietly building a case for the same ideas. Not in a monastery. Not in a philosophy department. In a psychiatric research lab.
Oxford’s Mindfulness Research Centre, housed within its Department of Psychiatry, has spent over two decades studying what happens when people learn to pay attention to their own minds. And over those years, something interesting has happened. The research has expanded far beyond its original scope of treating depression. It now stretches into schools, prisons, workplaces, the UK Parliament, and general populations worldwide. That expansion isn’t just about proving mindfulness “works.” It reflects something much bigger: a shift in how Western science understands our inner lives and what it means to be mentally well.
This is worth examining carefully, whether you meditate or not. This is not treatment advice: the evidence below concerns particular populations and structured programmes, and it should not be generalized to every mindfulness exercise or every person.
The original question: Can mindfulness prevent depression from coming back?
The story starts with a specific clinical problem.
Recurrent depression carries a risk of relapse, but the risk varies by a person’s history and the population studied. A 2007 review reported high lifetime recurrence estimates; it is not a current estimate for every person who has experienced depression. Maintenance antidepressants are one evidence-based option, with duration individualized and longer treatment recommended for some people at higher risk of relapse.
In the early 2000s, researchers Mark Williams, John Teasdale, and Zindel Segal developed Mindfulness-Based Cognitive Therapy (MBCT), a structured relapse-prevention programme combining cognitive therapy with mindfulness practice. Depending on the clinical context, it may be offered alongside usual care or as an alternative to another active treatment; it is not equivalent to a brief self-guided exercise.
Oxford became a major centre for this research. A 2016 individual-patient-data meta-analysis in JAMA Psychiatry, led by Willem Kuyken, pooled nine randomised trials. Across the combined non-MBCT comparison groups, MBCT was associated with a 31% lower hazard of relapse over 60 weeks. The study reported comparable outcomes when MBCT was compared specifically with other active treatments, including maintenance antidepressants, and greater relative benefit among participants with higher baseline depressive symptoms.
That’s where it started. But that’s not where it stayed.
What the MYRIAD trial actually revealed (and why it matters more than the headlines suggest)
The MYRIAD trial is worth looking at closely, because it’s a good example of how honest research can look like a failure while actually being something much more interesting.
The headline result was that school-based mindfulness training, delivered to over 8,000 UK teenagers aged 11 to 14, showed no significant advantage over normal social-emotional teaching in reducing depression risk or improving wellbeing at one-year follow-up. That’s what made the news.
But here’s what didn’t make most headlines. The trial did find evidence that mindfulness training improved teacher mental health, particularly burnout. It found that the training was rated more positively by students from more deprived schools. And it raised important questions about whether universal, one-size-fits-all mindfulness programmes are the right approach for early adolescents, or whether more targeted, voluntary approaches might work better.
The trial did not test every possible use of mindfulness with young people. It did show that this universal school programme was not superior to teaching as usual on its main pupil outcomes. Ideas about more targeted or voluntary approaches remain questions for further research, not a positive result from this trial.
From clinical tool to understanding what wellbeing actually is
When I was in my mid-twenties, working a warehouse job in Melbourne and reading about Buddhism on my phone during breaks, I wasn’t depressed in any clinical sense. I was lost. Anxious. Disconnected from any sense of purpose. My Graduate Diploma of Psychological Studies from Deakin University had taught me how the mind works in theory, but it hadn’t given me much to work with when I was stacking TVs at 6 AM and wondering what I was doing with my life.
What Buddhism offered me was a way to pay closer attention to experience. Some Oxford programmes study related skills, but that personal interpretation should not be presented as a finding that wellbeing itself is a trainable skill for everyone.
The expanding scope of the research reflects interest in attention, prevention, and wellbeing beyond acute treatment. It does not establish that mindfulness is a practical necessity for every healthy person, or that one approach to inner life fits everyone.
Oxford’s newer programmes reflect this. MBCT-Taking it Further, for instance, is specifically designed for people who’ve already completed a basic mindfulness course and want to go deeper, not because they’re unwell, but because they recognise that the quality of their attention shapes the quality of their life.
What people get wrong about this shift
There’s a common misunderstanding that needs addressing. When research institutions like Oxford expand mindfulness programmes beyond clinical settings, sceptics often interpret this as “mindfulness has gone mainstream and lost its rigour.” The reality is closer to the opposite.
Oxford researchers have tested several structured programmes and have also published null or mixed results. Evidence differs by programme, population, comparator, and outcome, so the existence of a trial in one setting should not be treated as validation of mindfulness in every other setting.
Another misconception is that this research validates every mindfulness app, weekend workshop, and Instagram meditation account.
It doesn’t.
Oxford’s findings are specific to structured, well-taught programmes delivered by trained instructors. There’s a significant difference between evidence-based mindfulness training and someone telling you to “just breathe” over a sunset photo.
A third trap is treating clinical evidence as validation of every philosophical claim associated with mindfulness. Oxford’s interest in human flourishing can sit alongside Buddhist traditions, but shared language does not make the scientific and contemplative claims identical.
What this means for your actual life
I meditate every day. Some days it’s five minutes. Some days it’s thirty. The length has never been the point. What matters is the consistency of turning toward my own experience instead of running from it, a habit I first built during those warehouse breaks in Melbourne, and one I’ve carried through moving overseas, starting a family, and building a business with my brothers.
The Oxford studies suggest that specific, structured programmes can affect particular outcomes in particular groups. My belief that attention can be trained more broadly comes from personal practice; it is not a universal conclusion established by those trials.
Practices that cultivate awareness may help some people notice automatic reactions and habitual thought patterns. In MBCT, skills such as decentring and self-compassion are taught within a structured therapeutic programme. That overlaps with some contemplative ideas without proving that the two traditions make the same claim.
A 2-minute practice
Right now, wherever you are, do this.
Close your eyes (or soften your gaze). Take three slow breaths. On each exhale, silently name one thing you can notice in your direct experience right now, whether a sound, a physical sensation, or the feeling of the air on your skin.
After three breaths, ask yourself one question: “What’s here that I wasn’t noticing?”
Sit with whatever comes up for another thirty seconds. Then open your eyes and carry on.
That’s it. Two minutes.
This is an optional brief grounding prompt, not the structured MBCT or school programme studied in the research above. The cited evidence does not establish that a two-minute exercise is an effective dose or that repeating it will change a person’s mental-health trajectory. If closing your eyes or focusing inward feels destabilising, stop or keep your eyes open and orient to the room instead.
Common traps
- Treating mindfulness research as either total validation or total debunking. The evidence is nuanced, and that’s what makes it trustworthy. Mixed results (like the MYRIAD trial) are a feature of good science, not a flaw.
- Assuming that because a university studies it, mindfulness is now “owned” by Western science. The research tradition at Oxford explicitly acknowledges that it’s building on 2,500 years of contemplative wisdom. This is integration, not appropriation.
- Assuming more practice guarantees a better outcome. Engagement may matter in some programmes, but the Oxford findings do not establish a universal dose-response rule, and individual responses vary.
- Using mindfulness in place of appropriate care. A brief practice may be useful for some people, but it should not replace or delay professional support for depression, crisis, or worsening symptoms.
A simple takeaway
- Oxford’s mindfulness research has expanded from treating depression to studying human flourishing, prevention, education, and systemic wellbeing.
- The expansion shows scientific interest in prevention and wellbeing, while results still depend on the population, programme, and outcome.
- The MYRIAD trial’s mixed results on school-based mindfulness are a reminder that how and for whom mindfulness is delivered matters as much as whether it “works.”
- Mindfulness may be one way some people cultivate attention; it is not a universal definition of wellbeing.
- The two-minute prompt above is optional and should not be confused with the structured programmes studied at Oxford.
- Contemplative traditions and modern research sometimes overlap, but the evidence is narrower than the philosophy.
Did you like my article? Like me on Facebook to see more articles like this in your feed.
